Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03700177Phase 4Unknown
Phase 4, randomised, double-blind trial in postoperative pain comparing Ropivacaine + Dexamethasone with Ropivacaine + Placebo (2 arms). Primary endpoint: Morphine consumption in the first 72 hours. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03700177.